Cedar
Cedar Company Growth, Stability & Outlook
Frequently Asked Questions
Cedar is post-Series D and profitable — a milestone most companies at our stage never reach. Our Chief People Officer notes: "We started from just a seed, our founders in a closet at one of our investors' offices, to a company that has almost 450 people. There are so many milestones that Cedar has achieved in the last several years that most companies never see." That financial foundation means we're building for the long term, not burning toward an exit.
Cedar occupies a rare and defensible position: we are a tech-native company with nearly a decade of healthcare domain expertise, a proven integration footprint across major health systems, and an AI capability that newer entrants simply can't match without our data history.
A leader in Engineering describes it clearly: "We are not one of those incumbents who have existed for multiple decades. At the same time, there are a lot of interesting AI-native upstarts who are trying to disrupt healthcare through innovative products. However, they lack the experience and expertise of integrating into the healthcare ecosystem. Cedar has been around for a decade, so we understand these workflows." We are exactly at the intersection where experience and innovation meet.
We are growing into a healthcare affordability crisis that is getting worse, not better. The patient financial experience problem is expanding — more self-pay patients, rising deductibles, shifting coverage — and Cedar is purpose-built to address it at scale. Our product suite is expanding through AI-native products like Kora and Remi.
Our client base is deepening through partnerships with health systems that see Cedar as a strategic partner, not a vendor. And our technology advantage is compounding: every patient interaction makes our system smarter.
One of the things that distinguishes Cedar as an employer at this stage is that the company has actually survived. We've navigated the “post-zero interest rate policy” environment, achieved profitability, and emerged in a stronger position than many of our peers.
We're a mature, profitable, mission-driven company still operating with startup intensity because the mission demands it.
What People Are Saying About Cedar
-
Product Line Growth: Product launches such as expanded Cedar Intelligence for billing, the Kora AI voice agent, and affordability tools indicate a steady cadence of feature expansion. These additions broaden use cases from post‑visit billing into coverage, affordability, and automated support.
-
Market Expansion: New deployments and marketplace integrations (e.g., health‑system wins, ambulatory channels, and marketplace distribution) show expanding reach across health systems, medical groups, and practices. Such channels open growth vectors beyond large enterprise hospital deals.
-
Strategic Partnerships: Partnerships and ecosystem collaborations (e.g., marketplace integrations and communications platforms) support scale and adoption. An acquisition expanding payer–provider workflows further extends platform breadth and go‑to‑market leverage.
